Regenerative Biologics
Regenerative Biologics is a Florida-based tissue recovery organization that procures placenta, cord blood, and cadaveric tissues from donors for transplantation, research, and education, serving hospitals and tissue processing companies under B2B transaction-based contracts.
- Company typePrivate
- Founded2017
- HeadquartersGainesville, United States
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Regenerative Biologics does
Regenerative Biologics, Inc. (RBI) is a Florida-based tissue recovery organization that recovers human tissues from both cadaveric and living donors for use in transplantation, research, and education. The company's core services include placenta donation, umbilical cord blood donation, and broader tissue recovery operations conducted at partner hospitals across Florida. Recovered tissues are distributed to leading tissue processing companies and healthcare providers for further processing and downstream use in regenerative medicine applications.
RBI's operations are built around a B2B relationship model with hospitals, where the company coordinates donor identification, family support, tissue recovery, and regulatory compliance at the point of donation. The organization also engages in community outreach, health professional education, and donation-related research to increase tissue supply. Its revenue model is transaction-based, with fees negotiated with healthcare partners for tissue recovery services; pricing is not publicly disclosed.
The company is headquartered at 13400 Progress Blvd, Alachua, Florida 32615, and operates exclusively within Florida under the state's regulatory framework for tissue donation. As of March 2026, RBI announced a major expansion into stem cell therapy offerings — including live umbilical-derived stem cell treatments and personalized stem cell banking through culture expansion and cryopreservation — enabled by Florida's updated stem cell regulatory framework. This pivot marks a strategic broadening from pure tissue procurement toward patient-facing regenerative therapy services.
Regenerative Biologics firmographics
Firmographics- Name
- Regenerative Biologics
- Legal name
- Regenerative Biologics, Inc.
- Website
- https://rbidonorcare.org
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Regenerative Biologics is a Florida-based tissue recovery organization that procures placenta, cord blood, and cadaveric tissues from donors for transplantation, research, and education, serving hospitals and tissue processing companies under B2B transaction-based contracts.
- Ownership category
- akta.pro rank
Regenerative Biologics industry classification
Industry- Product category
- Tissue Recovery Services
- NAICS
- Blood and Organ Banks (621991), Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Stem Cell–Based Regenerative Therapies (HLAAAGAA)
- akta.pro secondary industries
- Skin Substitutes & Biologic/Regenerative Wound Therapies (Matrices, Grafts) (HLAHALAE), Wound Healing & Skin Regeneration (advanced dressings, skin substitutes) (HLAAAGAG)
Keywords
Where Regenerative Biologics is headquartered
LocationHeadquarters
- HQ city
- Gainesville
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Regenerative Biologics business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Supply Chain, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Tissue Recovery Services: Recovery of human tissues (placenta, cord blood, cadaveric and living tissue) from donors and distribution to tissue processing companies and healthcare providers for transplantation and research.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Regenerative Biologics product offering
Product offeringCore offering
Regenerative Biologics is a not-for-profit tissue recovery organization that recovers human tissues—including placenta, umbilical cord blood, and cadaveric and living donor tissues—at partner hospitals in Florida. Recovered tissues are distributed to leading tissue processing companies for transplantation, research, and education. The organization also supports donor families, educates health professionals, and is expanding into live umbilical-derived stem cell treatments and personalized stem cell banking.
Product overview
Regenerative Biologics is a tissue donation and recovery organization providing human tissues for transplantation, research, and education. The company operates a placenta donation program, cord blood donation service, and tissue recovery services at partner hospitals throughout Florida. These services work together to enable the collection and distribution of human biological tissues that support regenerative medicine applications and save patient lives through transplantation.
Differentiator
Problem solved
Functional benefit
Products and services
- Placenta Donation Placenta donation program that allows mothers to donate placental tissue after childbirth for use in transplantation and research purposes.
- Cord Blood Donation Umbilical cord blood donation service where donated cord blood containing blood-forming cells may help save the lives of patients needing transplants for life-threatening diseases.
- Tissue Recovery Services Tissue recovery operations conducted at partner hospitals where RBI recovers human tissues and provides them to leading tissue processing companies for transplantation and research.
Companies that use Regenerative Biologics
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles2 records
Regenerative Biologics technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Regenerative Biologics partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- HospitalscoreRBI partners with hospitals to recover tissues including placenta and cord blood from donors. The partnership includes applications for hospitals to become partners, with RBI handling donor coordination, tissue recovery, and compliance with regulatory requirements. RBI also supports hospital staff education and provides resources for donor family support.
Scale indicators1 record
Recent moves3 records
Expansion highlights2 records
Regenerative Biologics competitors and assessment
Company assessmentDirect peers
- MTF Biologics: National non-profit tissue recovery organization that recovers musculoskeletal, skin, and birth tissue from donors and distributes to tissue processors and hospitals — directly comparable to RBI's core tissue recovery model.
- LifeNet Health: Non-profit tissue recovery and processing organization offering allograft and birth-tissue products for transplantation and research, overlapping with RBI's placenta and tissue recovery services.
- Cryo-Cell International: U.S. cord blood and menstrual stem cell banking company serving consumer and family-banking customers — directly comparable to RBI's planned personal stem cell banking service.
- AlloSource: Non-profit that recovers and distributes human allograft tissues to hospitals and surgeons, comparable to RBI's hospital-partnered cadaveric and living tissue recovery model.
- Community Tissue Services: Non-profit tissue recovery organization partnering with hospitals to recover musculoskeletal and birth tissues, closely mirroring RBI's hospital-partnered tissue recovery operating model.
- Cord Blood Registry (CBR): Large U.S. private cord blood bank focused on family banking of newborn stem cells, overlapping with RBI's cord blood collection and planned culture-expansion banking service.
- ViaCord: Cord blood and cord tissue banking service providing personal family banking of hematopoietic stem cells — directly comparable to RBI's cord blood donation and planned personal banking offering.
Emerging players
- Celularity: Regenerative medicine company developing cellular therapies derived from the placenta and umbilical cord — adjacent to RBI's planned umbilical-derived stem cell therapy launch.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights5 records
Customer concentration
Regenerative Biologics social profiles
Digital presenceRegenerative Biologics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Regenerative Biologics leadership team
Management profileNumber of profiles
Regenerative Biologics funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Regenerative Biologics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Regenerative Biologics
What does Regenerative Biologics do?
Regenerative Biologics is a not-for-profit tissue recovery organization that recovers human tissues—including placenta, umbilical cord blood, and cadaveric and living donor tissues—at partner hospitals in Florida. Recovered tissues are distributed to leading tissue processing companies for transplantation, research, and education. The organization also supports donor families, educates health professionals, and is expanding into live umbilical-derived stem cell treatments and personalized stem cell banking.
Is Regenerative Biologics a public or private company?
Regenerative Biologics is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Regenerative Biologics founded?
Regenerative Biologics was founded in 2017. It employs 51 to 100 people.
Where is Regenerative Biologics based?
Regenerative Biologics is headquartered in Gainesville, United States, in the North America region.
How does Regenerative Biologics make money?
One revenue line is on record: tissue Recovery Services.
Who are Regenerative Biologics's main competitors?
Direct peers on record are MTF Biologics, LifeNet Health, Cryo-Cell International, AlloSource, Community Tissue Services, Cord Blood Registry (CBR) and ViaCord. Celularity is listed as an emerging player.
Does Regenerative Biologics have an API?
No public API is recorded for Regenerative Biologics.
What industry is Regenerative Biologics in?
Regenerative Biologics's product category is Tissue Recovery Services. Its primary akta.pro industry code is HLAAAGAA, Stem Cell–Based Regenerative Therapies, with a secondary code of HLAHALAE, Skin Substitutes & Biologic/Regenerative Wound Therapies (Matrices, Grafts). Its NAICS code is 621991 and its SIC code is 2836.